Please use this identifier to cite or link to this item:
|Title:||Asymptomatic carotid artery stenosis.||Austin Authors:||Chambers, Brian R ;Roberts, Neil G||Affiliation:||email@example.com
National Stroke Research Institute, Department of Medicine, University of Melbourne, Austin Health, 300 Waterdale Road, Heidelberg Heights, 3081, Victoria, Australia
|Issue Date:||1-Apr-2007||Publication information:||Current Treatment Options in Cardiovascular Medicine; 9(2): 81-9||Abstract:||Severe asymptomatic carotid stenosis is associated with a stroke risk of approximately 2% per annum. Aggressive management of risk factors is recommended, including cessation of smoking, and treatment of hypertension, diabetes, and hypercholesterolemia. Patients should be treated with antiplatelet agents. Carotid endarterectomy (CEA) in patients with greater than or equal to 60% stenosis reduces the risk of stroke by approximately 1% per annum overall. The benefit is greatest for men and younger patients. There may be no benefit for women or for older patients. Carotid angioplasty and stenting is not recommended as an alternative to CEA until there is clinical trial evidence of efficacy in asymptomatic stenosis, except in some patients with technical contraindications to CEA. There is no evidence that patients with asymptomatic severe carotid stenosis should undergo carotid revascularization prior to other surgical procedures, including coronary bypass surgery.||Gov't Doc #:||17484810||URI:||http://ahro.austin.org.au/austinjspui/handle/1/10374||URL:||https://pubmed.ncbi.nlm.nih.gov/17484810||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 7, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.